Table 1 Characterization of the tumor series, conserning tumor pathological features and molecular markers
From: SRC inhibition prevents P-cadherin mediated signaling and function in basal-like breast cancer cells
N | % | ||
|---|---|---|---|
Histological grade | 1 | 75 | 18.0 |
2 | 117 | 28.1 | |
3 | 204 | 49.0 | |
Missing | 20 | 4.8 | |
ERα | Negative | 140 | 33.7 |
Positive | 274 | 65.9 | |
Missing | 2 | 0.5 | |
HER2 | Negative | 352 | 84.6 |
Positive | 60 | 14.4 | |
Missing | 4 | 1.0 | |
EGFR | Negative | 395 | 95.0 |
Postive | 21 | 5.0 | |
Missing | 0 | 0.0 | |
CKS | Negative | 357 | 85.8 |
Positive | 59 | 14.2 | |
Missing | 0 | 0.0 | |
CK14 | Negative | 394 | 94.7 |
Postive | 22 | 5.3 | |
Missing | 0 | 0.0 | |
Vimentin | Negative | 345 | 82.9 |
Postive | 69 | 16.6 | |
Missing | 2 | 0.5 | |
CD44 | Negative | 205 | 49.3 |
Positive | 210 | 50.5 | |
Missing | 1 | 0.2 | |
Subtype | Luminal | 303 | 72.8 |
Her2 | 29 | 7.0 | |
Triple-Negative | 84 | 20.2 | |
Missing | 0 | 0.0 | |